US Patent

US9387249 — Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone

Method of Use · Assigned to Takeda Pharmaceutical Co Ltd · Expires 2031-07-01 · 5y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a method of treating hypertension in a subject by administering at least one angiotensin II receptor blocker and chlorthalidone.

USPTO Abstract

The present invention relates to a method of treating hypertension in a subject or patient needing treatment thereof by administering to said subject or patient at least one angiotensin II receptor blocker in combination with chlorthalidone.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3`	Treatment of inflammatory conditions
`U-3`	Treatment of inflammatory conditions

Patent Metadata

Patent number: US9387249
Jurisdiction: US
Classification: Method of Use
Expires: 2031-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Takeda Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.